期刊文献+

A Novel Functional Missense Mutation p.T219A in Type Gaucher's Disease

A Novel Functional Missense Mutation p.T219A in Type Gaucher's Disease
原文传递
导出
摘要 Background: Gaucher's disease (GD) is an autosomal recessive disorder caused by a deficiency of acid β-glucosidase (glucocerebrosidase [GBA]) that results in the accumulation of glucocerebroside within macrophages. Many mutations have been reported to be associated with this disorder. This study aimed to discover more mutations and provide data for the genetic pattern of the gene, which will help the development of quick and accurate genetic diagnostic tools for this disease. Methods: Genomic DNA was obtained from peripheral blood leukocytes of the patient and Sanger sequencing is used to sequence GBA gene. Sequence alignments of mammalian β-GBA (GCase) and three-dimensional protein structure prediction of the mutation were made. A construct of this mutant and its compound heterozygous counterpart were used to measure GCase in vitro. Results: GCase is relatively conserved at p.T219A. This novel mutation differs from its wild-type in structure. Moreover, it also causes a reduction in GCase enzyme activity. Conclusion: This novel mutation (c.655A〉G, p.T219A) is a pathogenic missense mutation, which contributes to GD. Background: Gaucher's disease (GD) is an autosomal recessive disorder caused by a deficiency of acid β-glucosidase (glucocerebrosidase [GBA]) that results in the accumulation of glucocerebroside within macrophages. Many mutations have been reported to be associated with this disorder. This study aimed to discover more mutations and provide data for the genetic pattern of the gene, which will help the development of quick and accurate genetic diagnostic tools for this disease. Methods: Genomic DNA was obtained from peripheral blood leukocytes of the patient and Sanger sequencing is used to sequence GBA gene. Sequence alignments of mammalian β-GBA (GCase) and three-dimensional protein structure prediction of the mutation were made. A construct of this mutant and its compound heterozygous counterpart were used to measure GCase in vitro. Results: GCase is relatively conserved at p.T219A. This novel mutation differs from its wild-type in structure. Moreover, it also causes a reduction in GCase enzyme activity. Conclusion: This novel mutation (c.655A〉G, p.T219A) is a pathogenic missense mutation, which contributes to GD.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第9期1072-1077,共6页 中华医学杂志(英文版)
基金 This study was supported by grants from Natural Science Foundation of China (No. 81371269) and Shanghai Research Program (No. 14140902600, No. 2013ZYJB0015, and No. 14DJ 1400103).
关键词 Gaucher's Disease GCase GENETICS Novel Missense Mutation Gaucher's Disease GCase Genetics Novel Missense Mutation
  • 相关文献

参考文献29

  • 1Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond. Mov Disord 2011;26:1593-604. doi: 10.1002/rods.23774.
  • 2Grabowski GA. Gaucher disease and other storage disorders. Hematology Am Soc Hematol Educ Program 2012;2012:13-8. doi: 10.1182/asheducation-2012.1.13.
  • 3Chen M, Wang J. Gaucher disease: Review of the literature. Arch Pathol Lab Med 2008; 132:851-3. doi: 10.1043/1543-2165(2008) 132 [851 :GD ROTL] 2.0.CO;2.
  • 4Bendikov-Bar I, Horowitz M. Gaucher disease paradigm: From ERAD to comorbidity. Hum Mutat 2012;33:1398-407. doi: 10.1002/ humu.22124.
  • 5Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet 2008;372:1263-71. doi: 10.1016/ sO 140-6736(08)61522-6.
  • 6Martins AM, Valadares ER, Porta G, Coelho J, Semionato Filho J, Pianovski MA, et aL Recommendations on diagnosis, treatment, and monitoring for Gaucher disease. J Pediatr 2009;155 4 Suppl: S10-8. doi: 10.1016/j.jpeds.2009.07.004.
  • 7Lee JY, Lee BH, Kim GH, Jung CW, Lee J, Choi JH, et aL Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups. Korean J Pediatr 2012;55:48-53. doi: 10.3345/ kjp.2012.55.2.48.
  • 8Campbell TN, Choy FY. Gaucher disease and the synucleinopathies: Refining the relationship. Orphanet J Rare Dis 2012;7:12. doi: 10.1186/1750-1172-7-12.
  • 9Zhang CK, Stein PB, Liu J, Wang Z, Yang R, Cho JH, et al. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am J Hematol 2012;87:377-83. doi: 10.1002/ajh.23118.
  • 10Montfort M, Chabfis A, Vilageliu L, Grinberg D. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms. Hum Mutat 2004;23:567-75. doi: 10.1002/humu.20043.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部